Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China
· Delayed Price · Currency is CNY 17.92
+0.19 (1.07%)
Apr 30, 2026, 1:04 PM CST
SHA:688670 Market Cap
SHA:688670 has a market cap or net worth of 2.18 billion as of April 29, 2026. Its market cap has increased by 48.99% in one year.
Market Cap
2.18B
Enterprise Value
2.14B
Revenue
110.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.92
Market Cap Chart
Since August 2, 2021, SHA:688670's market cap has decreased from 7.30B to 2.18B, a decrease of -70.06%. That is a compound annual growth rate of -22.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 2.18B | -12.36% |
| Dec 31, 2025 | 2.49B | 66.91% |
| Dec 31, 2024 | 1.49B | -57.41% |
| Dec 29, 2023 | 3.51B | -7.32% |
| Dec 30, 2022 | 3.78B | -43.20% |
| Dec 31, 2021 | 6.66B | -8.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu CoWin Biotech | 2.20B |
| Guiyang Xintian Pharmaceutical | 2.28B |
| Zhejiang East Asia Pharmaceutical | 2.37B |
| Shanghai Hile Bio-Technology | 2.51B |
| Shanghai Universal Biotech | 2.60B |
| Suzhou Fushilai Pharmaceutical | 2.61B |
| Cabio Biotech (Wuhan) | 2.65B |
| Jilin Jian Yisheng Pharmaceutical | 2.70B |